[go: up one dir, main page]

AR081565A1 - METHODS TO TREAT CANCER OF SENSITIVE OVARY TO PLATINUM RECURRENT WITH 4-IODO-3-NITROBENZAMIDE IN COMBINATION WITH AN ANTI-METABOLITE AND A PLATINUM COMPOUND - Google Patents

METHODS TO TREAT CANCER OF SENSITIVE OVARY TO PLATINUM RECURRENT WITH 4-IODO-3-NITROBENZAMIDE IN COMBINATION WITH AN ANTI-METABOLITE AND A PLATINUM COMPOUND

Info

Publication number
AR081565A1
AR081565A1 ARP110101903A AR081565A1 AR 081565 A1 AR081565 A1 AR 081565A1 AR P110101903 A ARP110101903 A AR P110101903A AR 081565 A1 AR081565 A1 AR 081565A1
Authority
AR
Argentina
Prior art keywords
platinum
nitrobenzamide
metabolite
iodo
sensitive
Prior art date
Application number
Other languages
Spanish (es)
Original Assignee
Bipar Sciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bipar Sciences Inc filed Critical Bipar Sciences Inc
Publication of AR081565A1 publication Critical patent/AR081565A1/en

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

La presente proporciona un método para tratar cáncer de ovario sensible a platino recurrente en un paciente, que comprende administrar al paciente una cantidad eficaz de la 4-yodo-3-nitrobenzamida o un metabolito o una sal farmacéuticamente aceptable de ésta; gemcitabina; y carboplatino.This provides a method of treating recurrent platinum-sensitive ovarian cancer in a patient, which comprises administering to the patient an effective amount of 4-iodo-3-nitrobenzamide or a metabolite or a pharmaceutically acceptable salt thereof; gemcitabine; and carboplatin.

ARP110101903 2010-06-04 2011-06-02 METHODS TO TREAT CANCER OF SENSITIVE OVARY TO PLATINUM RECURRENT WITH 4-IODO-3-NITROBENZAMIDE IN COMBINATION WITH AN ANTI-METABOLITE AND A PLATINUM COMPOUND AR081565A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US35178510P 2010-06-04 2010-06-04
US201161481634P 2011-05-02 2011-05-02

Publications (1)

Publication Number Publication Date
AR081565A1 true AR081565A1 (en) 2012-10-03

Family

ID=47146102

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP110101903 AR081565A1 (en) 2010-06-04 2011-06-02 METHODS TO TREAT CANCER OF SENSITIVE OVARY TO PLATINUM RECURRENT WITH 4-IODO-3-NITROBENZAMIDE IN COMBINATION WITH AN ANTI-METABOLITE AND A PLATINUM COMPOUND

Country Status (1)

Country Link
AR (1) AR081565A1 (en)

Similar Documents

Publication Publication Date Title
MX385872B (en) USE OF AN ANTIBODY THAT HAS THE ABILITY TO BIND TO CLND 6 IN THE TREATMENT OR PREVENTION OF CANCER
GB201114051D0 (en) Compounds and their uses
EA201790882A1 (en) METHODS AND COMPOSITIONS FOR LIVER CANCER THERAPY
BR112012026707A2 (en) use of an afucosylated anti-cd20 antibody, composition comprising an afucosylated anti-cd20 antibody and method of treating cancer patients by administering an afucosylated anti-cd20 antibody
MX362720B (en) ANTI-TROP-2 HUMAN ANTI-BODY THAT HAS AN IN VIVO ANTITUMORAL ACTIVITY.
BR112013001122A2 (en) therapeutic active compositions and their method of use
BR112015026006A2 (en) methods for treating cancer with the use of tor kinase inhibitor combination therapy
BR112015012295A8 (en) USE OF A WEE1 INHIBITOR, E, KIT TO IDENTIFY A PATIENT WITH CANCER
CU24196B1 (en) MONOCLONAL ANTIBODIES AGAINST PROGASTRINE
BR112016013861A2 (en) drug and antibody conjugates, compounds, treatment method and pharmaceutical composition
MX373925B (en) CANCER TREATMENT WITH TOR KINASE INHIBITORS.
BR112014012607A2 (en) treatment methods using an interferon gamma inhibitor
BR112014017840A8 (en) THERAPEUTICLY ACTIVE COMPOUNDS, THEIR PHARMACEUTICAL COMPOSITION AND THEIR USE
BR112013000651A2 (en) kinase inhibitor combinations for cancer treatment.
CL2011001232A1 (en) Pharmaceutical combination comprising an antibody that specifically recognizes cd38 and at least cytarabine; and its use for cancer treatment
BR112013002484A2 (en) compound, pharmaceutical composition, methods for treating multiple sclerosis and rheumatoid arthritis, and use of a compound.
BR112015018418A2 (en) methods for treating cancer, for increasing the effectiveness of a treatment, for postponing and / or preventing cancer development, for increasing sensitivity to a targeted therapy, to extending the sensitivity period, to extending the response duration to a targeted therapy. and pharmaceutical
BR112015023203A8 (en) methods for treating cancer, method for increasing the efficiency of cancer treatment, method for delaying and / or preventing cancer development, method for treating an individual with cancer, method for increasing sensitivity for a cancer therapy agent, method for extending a sensitivity period and method for extending the duration of response to cancer therapy.
BR112012022243A2 (en) thioxantone-based autograph inhibitor therapies to treat cancer
BR112013014522A2 (en) afucosylated anti-cd20 antibody and its use, composition and method for treating a cancer patient
MX377267B (en) CANCER TREATMENT WITH DIHYDROPYRAZINE-PYRAZINES.
MX2015014599A (en) COMBINATION THERAPY UNDERSTANDING A TOR CINASA INHIBITOR AND A CITIDINE ANALOG TO TRUCK CANCER.
AR097619A1 (en) USE OF ACETIL-COA CARBOXYLASE INHIBITORS TO TREAT ACNÉ VULGARIS
BR112013032456A2 (en) anti-cxcr4 antibody with effector functions and its use for cancer treatment
MX2011006725A (en) Combination of aurora kinase inhibitors and anti-cd20 antibodies.

Legal Events

Date Code Title Description
FB Suspension of granting procedure